Optimization of metabolic stability as a goal of modern drug design.
Metabolism and other pharmacokinetic (PK) studies have always played a critical role in helping to optimize the bioavailability and duration of action of new drugs thereby increasing their success rate. With the advent of automated combinatorial synthesis, high-throughput pharmacological testing, and the ability to create extensive databases in the past decade, drug discovery has undergone an amazing evolution. With the increased throughput of drug discovery, metabolism and other PK studies have evolved to keep pace. Often called "early ADME" studies, these studies are characterized by parallel processing and higher throughput than before. This article focuses on a particular class of early ADME (absorption, distribution mechanism, and excretion) studies known as "metabolic stability" studies. The theoretical basis for metabolic stability and its relationship to the concept of metabolic intrinsic clearance is briefly presented. Some key relationships between structure and metabolism are summarized. Several case studies from recent medicinal chemistry literature are reviewed to exemplify how metabolic stability studies influenced drug design and led to improvements in bioavailability and half-life. Finally, future trends in drug metabolism and analytical chemistry and how they may influence metabolic stability studies are reviewed.
Thompson
T N
TN
Early ADME/Drug Metabolism, Quintiles, Inc., Kansas City, Missouri 66134-0708, USA. tom.thompson@quintiles.com
D000581:Amidohydrolases / Q000502:physiology; D000818:Animals; D015195:Drug Design; D004950:Esterases / Q000502:physiology; D006801:Humans; D006868:Hydrolysis; D008657:Metabolic Clearance Rate; D010084:Oxidation-Reduction; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D013379:Substrate Specificity
D004364:Pharmaceutical Preparations; D004950:Esterases; D000581:Amidohydrolases